The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

Christian H Faul, Mary Donnelly, Sandra M Merscher-gomez, Yoon Hee Chang, Stefan Franz, Jacqueline Delfgaauw, Jer Ming Chang, Hoon Young Choi, Kirk N. Campbell, Kwanghee Kim, Jochen Reiser, Peter Mundel

Research output: Contribution to journalArticle

609 Citations (Scopus)

Abstract

The immunosuppressive action of the calcineurin inhibitor cyclosporine A (CsA) stems from the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also used for the treatment of proteinuric kidney diseases. As it stands, the antiproteinuric effect of CsA is attributed to its immunosuppressive action. Here we show that the beneficial effect of CsA on proteinuria is not dependent on NFAT inhibition in T cells, but rather results from the stabilization of the actin cytoskeleton in kidney podocytes. CsA blocks the calcineurin-mediated dephosphorylation of synaptopodin, a regulator of Rho GTPases in podocytes, thereby preserving the phosphorylation-dependent synaptopodin-14-3-3β interaction. Preservation of this interaction, in turn, protects synaptopodin from cathepsin L-mediated degradation. These results represent a new view of calcineurin signaling and shed further light on the treatment of proteinuric kidney diseases. Novel calcineurin substrates such as synaptopodin may provide promising starting points for antiproteinuric drugs that avoid the serious side effects of long-term CsA treatment.

Original languageEnglish
Pages (from-to)931-938
Number of pages8
JournalNature Medicine
Volume14
Issue number9
DOIs
StatePublished - Sep 1 2008

Fingerprint

Podocytes
Actin Cytoskeleton
Cyclosporine
Actins
Kidney
Calcineurin
NFATC Transcription Factors
T-cells
Kidney Diseases
Immunosuppressive Agents
Cell signaling
T-Lymphocytes
Cathepsin L
rho GTP-Binding Proteins
Phosphorylation
Proteinuria
Stabilization
Degradation
Substrates
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. / Faul, Christian H; Donnelly, Mary; Merscher-gomez, Sandra M; Chang, Yoon Hee; Franz, Stefan; Delfgaauw, Jacqueline; Chang, Jer Ming; Choi, Hoon Young; Campbell, Kirk N.; Kim, Kwanghee; Reiser, Jochen; Mundel, Peter.

In: Nature Medicine, Vol. 14, No. 9, 01.09.2008, p. 931-938.

Research output: Contribution to journalArticle

Faul, CH, Donnelly, M, Merscher-gomez, SM, Chang, YH, Franz, S, Delfgaauw, J, Chang, JM, Choi, HY, Campbell, KN, Kim, K, Reiser, J & Mundel, P 2008, 'The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A', Nature Medicine, vol. 14, no. 9, pp. 931-938. https://doi.org/10.1038/nm.1857
Faul, Christian H ; Donnelly, Mary ; Merscher-gomez, Sandra M ; Chang, Yoon Hee ; Franz, Stefan ; Delfgaauw, Jacqueline ; Chang, Jer Ming ; Choi, Hoon Young ; Campbell, Kirk N. ; Kim, Kwanghee ; Reiser, Jochen ; Mundel, Peter. / The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. In: Nature Medicine. 2008 ; Vol. 14, No. 9. pp. 931-938.
@article{f41b4c3c430f4cbbbb43342e9d8f290a,
title = "The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A",
abstract = "The immunosuppressive action of the calcineurin inhibitor cyclosporine A (CsA) stems from the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also used for the treatment of proteinuric kidney diseases. As it stands, the antiproteinuric effect of CsA is attributed to its immunosuppressive action. Here we show that the beneficial effect of CsA on proteinuria is not dependent on NFAT inhibition in T cells, but rather results from the stabilization of the actin cytoskeleton in kidney podocytes. CsA blocks the calcineurin-mediated dephosphorylation of synaptopodin, a regulator of Rho GTPases in podocytes, thereby preserving the phosphorylation-dependent synaptopodin-14-3-3β interaction. Preservation of this interaction, in turn, protects synaptopodin from cathepsin L-mediated degradation. These results represent a new view of calcineurin signaling and shed further light on the treatment of proteinuric kidney diseases. Novel calcineurin substrates such as synaptopodin may provide promising starting points for antiproteinuric drugs that avoid the serious side effects of long-term CsA treatment.",
author = "Faul, {Christian H} and Mary Donnelly and Merscher-gomez, {Sandra M} and Chang, {Yoon Hee} and Stefan Franz and Jacqueline Delfgaauw and Chang, {Jer Ming} and Choi, {Hoon Young} and Campbell, {Kirk N.} and Kwanghee Kim and Jochen Reiser and Peter Mundel",
year = "2008",
month = "9",
day = "1",
doi = "10.1038/nm.1857",
language = "English",
volume = "14",
pages = "931--938",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

AU - Faul, Christian H

AU - Donnelly, Mary

AU - Merscher-gomez, Sandra M

AU - Chang, Yoon Hee

AU - Franz, Stefan

AU - Delfgaauw, Jacqueline

AU - Chang, Jer Ming

AU - Choi, Hoon Young

AU - Campbell, Kirk N.

AU - Kim, Kwanghee

AU - Reiser, Jochen

AU - Mundel, Peter

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The immunosuppressive action of the calcineurin inhibitor cyclosporine A (CsA) stems from the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also used for the treatment of proteinuric kidney diseases. As it stands, the antiproteinuric effect of CsA is attributed to its immunosuppressive action. Here we show that the beneficial effect of CsA on proteinuria is not dependent on NFAT inhibition in T cells, but rather results from the stabilization of the actin cytoskeleton in kidney podocytes. CsA blocks the calcineurin-mediated dephosphorylation of synaptopodin, a regulator of Rho GTPases in podocytes, thereby preserving the phosphorylation-dependent synaptopodin-14-3-3β interaction. Preservation of this interaction, in turn, protects synaptopodin from cathepsin L-mediated degradation. These results represent a new view of calcineurin signaling and shed further light on the treatment of proteinuric kidney diseases. Novel calcineurin substrates such as synaptopodin may provide promising starting points for antiproteinuric drugs that avoid the serious side effects of long-term CsA treatment.

AB - The immunosuppressive action of the calcineurin inhibitor cyclosporine A (CsA) stems from the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also used for the treatment of proteinuric kidney diseases. As it stands, the antiproteinuric effect of CsA is attributed to its immunosuppressive action. Here we show that the beneficial effect of CsA on proteinuria is not dependent on NFAT inhibition in T cells, but rather results from the stabilization of the actin cytoskeleton in kidney podocytes. CsA blocks the calcineurin-mediated dephosphorylation of synaptopodin, a regulator of Rho GTPases in podocytes, thereby preserving the phosphorylation-dependent synaptopodin-14-3-3β interaction. Preservation of this interaction, in turn, protects synaptopodin from cathepsin L-mediated degradation. These results represent a new view of calcineurin signaling and shed further light on the treatment of proteinuric kidney diseases. Novel calcineurin substrates such as synaptopodin may provide promising starting points for antiproteinuric drugs that avoid the serious side effects of long-term CsA treatment.

UR - http://www.scopus.com/inward/record.url?scp=51349162919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349162919&partnerID=8YFLogxK

U2 - 10.1038/nm.1857

DO - 10.1038/nm.1857

M3 - Article

C2 - 18724379

AN - SCOPUS:51349162919

VL - 14

SP - 931

EP - 938

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -